Reply

Gastroenterology. 2020 Mar;158(4):1175-1176. doi: 10.1053/j.gastro.2019.12.023. Epub 2020 Jan 7.

Authors

Paul Moayyedi¹, John Eikelboom¹, Salim Yusuf¹

Affiliation

¹ The Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

PMID: 31917257
DOI: 10.1053/j.gastro.2019.12.023

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin
Humans
Proton Pump Inhibitors*
Rivaroxaban*

Substances

Proton Pump Inhibitors
Rivaroxaban
Aspirin